Stay updated with breaking news from Pharma Services. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Mitsubishi UFJ Asset Management UK Ltd. lifted its holdings in NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 13.9% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 41,000 shares of the medical research company’s stock after acquiring an additional 5,000 shares during the quarter. […]
/PRNewswire/ -- The pharmaceutical contract research and manufacturing (CRAM) market is expected to grow by USD 121.35 billion from 2022 to 2027. In addition,...
/PRNewswire/ -- The "Global Clinical Trial Supplies Market by Services (Manufacturing, Packaging, Logistics), Phases, Type (Small Molecules, Biologics),...
NeoGenomics (NASDAQ:NEO – Get Free Report) and Applied DNA Sciences (NASDAQ:APDN – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, profitability, valuation, risk and earnings. Profitability This table compares NeoGenomics and Applied […]
Emerald Advisers LLC raised its stake in NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 16.4% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,927,074 shares of the medical research company’s stock after acquiring an additional 270,855 shares during the period. NeoGenomics comprises about […]